Cargando…

Monoclonal Antibodies and Flaviviruses: a Possible Option?

M. P. Doyle, J. R. Genualdi, A. L. Bailey, N. Kose, et al. (mBio 13:e00512-22, 2022, https://doi.org/10.1128/mBio.00512-22), report on the cloning of a panel of fully human monoclonal antibodies (mAbs) directed against yellow fever virus (YFV). In particular, mAb YFV-136 is endowed with interesting...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mancini, Nicasio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239274/ https://www.ncbi.nlm.nih.gov/pubmed/35575500 http://dx.doi.org/10.1128/mbio.00824-22

Ejemplares similares

Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections
por: Sautto, Giuseppe, et al.
Publicado: (2013)

Flavivirus Cell Entry and Membrane Fusion
por: Smit, Jolanda M., et al.
Publicado: (2011)

Developing Monoclonal Antibodies for Immunohistochemistry
por: Cordell, Jacqueline
Publicado: (2022)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

The Combination of Dupilumab with Other Monoclonal Antibodies
por: Gisondi, P., et al.
Publicado: (2022)

Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
por: Sautto, Giuseppe, et al.
Publicado: (2013)

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination
por: Kaaijk, Patricia, et al.
Publicado: (2017)

Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens
por: Clementi, Nicola, et al.
Publicado: (2012)

Fibrates: A Possible Treatment Option for Patients with Abdominal Aortic Aneurysm?
por: Amioka, Naofumi, et al.
Publicado: (2022)

Immunocytochemical Labelling of Haematological Samples Using Monoclonal Antibodies
por: Erber, Wendy N.
Publicado: (2021)

Monoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?
por: Eccles, Suzanne A
Publicado: (2001)

EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018)

Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses
por: Chen, Lin H., et al.
Publicado: (2016)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
por: Martelletti, Paolo
Publicado: (2020)

Immune Checkpoint Glycoproteins Have Polymorphism: Are Monoclonal Antibodies Too Specific?
por: Jalalizadeh, Mehrsa, et al.
Publicado: (2023)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
por: Musto, Pellegrino
Publicado: (2018)

Flavivirus-induced antibody cross-reactivity
por: Mansfield, Karen L., et al.
Publicado: (2011)

Development of Antibody Therapeutics against Flaviviruses
por: Sun, Haiyan, et al.
Publicado: (2017)

Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
por: Landgren, Ola, et al.
Publicado: (2023)

An update to monoclonal antibody as therapeutic option against COVID-19
por: Deb, Paroma, et al.
Publicado: (2021)

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
por: Deng, Yong-Qiang, et al.
Publicado: (2011)

Thermodynamic Mechanism for the Evasion of Antibody Neutralization in Flaviviruses
por: Maillard, Rodrigo A., et al.
Publicado: (2014)

Zika, Flavivirus and Malaria Antibody Cocirculation in Nigeria
por: Mac, Peter Asaga, et al.
Publicado: (2023)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
por: Berges, Maja, et al.
Publicado: (2022)

One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I
por: Saelens, Xavier
Publicado: (2016)

Platform process for production of monoclonal antibodies for research purposes – improvement option
por: Petersen, Joern Meidahl, et al.
Publicado: (2011)

SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
por: Wolfe, Ian D., et al.
Publicado: (2021)

SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
por: Casadevall, Arturo, et al.
Publicado: (2023)

Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodies
por: Luangaram, Prasit, et al.
Publicado: (2022)

Flaviviruses
Publicado: (2005)

Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
por: Shao, Shuai, et al.
Publicado: (2022)

A novel mechanism of antibody-mediated enhancement of flavivirus infection
por: Haslwanter, Denise, et al.
Publicado: (2017)

Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site
por: Burioni, Roberto, et al.
Publicado: (2008)

Treatment options of lymphangioma circumscriptum
por: Puri, Neerja
Publicado: (2015)

Memory B cell and antibody responses to flavivirus infection and vaccination
por: Adam, Awadalkareem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t14fpok20np4dkagqi4dso3f67